September 15, 2026-September 16, 2026 Register Now: C-Path’s 2026 Global Impact Conference C-Path's flagship event is set to return to downtown Washington, D.C. this September 15-16 at the...
June 5, 2026 Public Private Partnerships for Rare Neurodegenerative Disease Critical Path Institute's Critical Path for Rare Neurodegenerative Diseases consortium, will convene partners from the FDA...
May 29, 2026 ALS Awareness Month: Connecting the Dots in ALS Research A single clinical study can generate millions of data points. For more than a year, people living with amyotrophic lateral scleros
May 26, 2026 Huntington’s Disease Awareness Month: Advancing Drug Development Through Lived Experience Each May, Huntington’s Disease Awareness Month serves as an important opportunity to raise visibility for...
May 22, 2026 Moving Treatments Across the Finish Line: A Focus for ALS Awareness Month Twenty-four years ago, Fernando Vieira lost his best friend to amyotrophic lateral sclerosis (ALS). Driven by that loss, he joined
May 20, 2026 Critical Path Institute Awards $249,719 Grant to Odylia Therapeutics to Advance Gene Therapy for USH1C-Associated Vision Loss TUCSON, Ariz., May 20, 2026 — Critical Path Institute® (C-Path) today announced the award of a $249,719 research grant...
May 19, 2026 Critical Path Institute Launches New Approach Methodologies Developer Coalition to Advance Human-Relevant Tools for Drug Development TUCSON, Ariz., and AMSTERDAM, May 19, 2026 — Critical Path Institute® (C-Path) today announced the launch of the New...
May 19, 2026 Advancing Hope in Progressive Supranuclear Palsy: Collaboration, Data, and Innovation During PSP Awareness Month Each May, Progressive Supranuclear Palsy (PSP) Awareness Month shines a light on a devastating neurodegenerative disease...
May 15, 2026 Parkinson’s Disease in Women: Research Gaps, Treatment Challenges, and New Hope Through GEM-PD May is Women’s Health Month and in observation, Bio.News sat down with Ragasudha Botta, MBBS, PhD, MMSc, Senior Scientific...
May 14, 2026 The Critical Path Institute Podcast: Accelerating Drug Development in Friedreich’s Ataxia, with Ron Bartek The newest Critical Path Institute® (C-Path) podcast features Ron Bartek, president and co-founder of the Friedreich’s Ataxia
